Skip to main content

Becton Dickinson Value Stock - Dividend - Research Selection

Becton Dickinson

ISIN: US0758871091, WKN: 857675

Market price date: 06.07.2022
Market price: 246,28 USD


Becton Dickinson Fundamental data and company key figures of the share

Annual reports in USD
Key figures 11-11-2021
Cash flow
Net operating cash flow 4.647.000.000
Capital Expenditures -1.231.000.000
Free cash flow 3.416.000.000
Balance sheet
Total Equity 53.866.000.000
Liabilities & Shareholders equity 53.866.000.000
Income statement
Net income 2.092.000.000
Eps (diluted) 7,127
Diluted shares outstanding 293.547.000
Net sales/revenue 20.248.000.000

Fundamental ratios calculated on: 06-07-2022

Ratios
Key figures 06-07-2022
Cash flow
P/C 15,56
   
P/FC 21,16
Balance sheet
ROI3,88
ROE100,00
Income statement
P/E34,56
Div. Yield1,35%
P/B1,34
P/S3,57


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolBDX
Market Capitalization72.294.752.256,00 USD
CountryUnited States
IndicesMSCI World Index,S&P 500
SectorsHealth Care Equipment
Raw Data SourceUS GAAP in Millionen USD
Stock Split2022-04-01,1025.000000/1000.000000; 1998-08-22,2.0000/1.0000; 1998-08-21,2.0000/1.0000; 1996-08-17,2.0000/1.0000; 1996-08-16,2.0000/1.0000; 1993-03-02,2.0000/1.0000; 1993-03-01,2.0000/1.0000; 1986-03-04,2.0000/1.0000; 1986-03-03,2.0000/1.0000
Internetwww.bd.com


Description of the company

Becton Dickinson and Co, formerly Becton Dickinson & Co is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company' s operations consist of three business segments: BD Medical, BD Diagnostics and BD Biosciences. On February 9, 2012, the Company acquired a 100% interest in KIESTRA Lab Automation BV. On August 24, 2012, the Company acquired a 100% interest in Sirigen Group Limited. On October 31, 2012, the Company sold its BD Biosciences -Discovery Labware unit. In December 2012, the Company acquired Safety Syringes, Inc. Effective March 12, 2013, the Company acquired Cato Software Solutions GmbH.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.bd.com


NEWS


Becton, Dickinson - BD Names Rishi Grover as Chief Integrated Supply Chain Officer

2022-07-06
FRANKLIN LAKES, N.J. - BD , a leading global medical technology company, announced that Rishi Grover has been named executive vice president and chief integrated supply chain officer for BD,... | July 6, 2022

Becton, Dickinson - BD Issues 2021 ESG Report

2022-07-06
FRANKLIN LAKES, N.J. - BD , a leading global medical technology company, issued its Fiscal Year 2021 Environmental, Social and Governance Report that details ongoing efforts that impact company... | July 6, 2022

BD Names Rishi Grover as Chief Integrated Supply Chain Officer

2022-07-05
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Rishi Grover has been named executive vice president (EVP) and chief integrated supply chain officer for BD, effective July 7, 2022.

With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case

2022-07-05
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

BD Issues 2021 ESG Report

2022-07-05
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its Fiscal Year 2021 Environmental, Social and Governance (ESG) Report that details ongoing efforts that impact company health, human health, community health and planet health.

Evercore adds Becton Dickinson to 'Tactical Underperform' list, lowers target

2022-07-05
Evercore ISI analyst Vija... BDX

Becton Dickinson names Rishi Grover as chief integrated supply chain officer

2022-07-05
Becton Dickinson announce... BDX

'Minions: The Rise of Gru' tops $108 million as parents flock back to cinemas, kids in tow

2022-07-03
"Minions: The Rise of Gru" generated more than $108 million in ticket sales during its domestic opening weekend.

BD's (BDX) New Combination Test to Boost Patient Outcome

2022-07-01
BD's (BDX) latest combination test is expected to speed up the detection of the infection-causing viruses, thereby accelerating the implementation of the appropriate treatment plan.

Rempart Asset Management Inc. Goes on Buying Spree in 2nd Quarter

2022-07-01